Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2000-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were
destroyed by chemotherapy or radiation therapy. Treating the peripheral stem cells in the
laboratory to remove any existing cancer cells may improve the effectiveness of the
transplant.
PURPOSE: Randomized phase II trial to compare the effectiveness of treated peripheral stem
cells with that of untreated stem cells in patients who have relapsed low- or
intermediate-grade non-Hodgkin's lymphoma.